Consolidative versus salvage stereotactic ablative radiotherapy to the primary lung tumor in stage IV non–small cell lung cancer - Top-Institutions - MDSpire

Consolidative versus salvage stereotactic ablative radiotherapy to the primary lung tumor in stage IV non–small cell lung cancer

  • By

  • Lisi Sun

  • Lulu Wang

  • Lina Yang

  • Wei Zhou

  • Yongzhong Wu

  • Dan Tao

  • July 15, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Radiation Oncology

  • #2

    Levine Cancer Institute, Atrium Health
    Levine Cancer Institute, Atrium Health

    Charlotte, North Carolina

    Key Differentiators

    • Radiation Oncology

  • #3

    Chongqing University Cancer Hospital
    Chongqing University Cancer Hospital

    Chongqing, China

    Key Differentiators

    • Radiation Oncology

  • #4

    Radiation Therapy Oncology Group
    Radiation Therapy Oncology Group

    Philadelphia, Pennsylvania

    Key Differentiators

    • Radiation Oncology

Original Source(s)

Consolidative versus salvage stereotactic ablative radiotherapy to the primary lung tumor in stage IV non–small cell lung cancer

  • by Lisi Sun, Lulu Wang, Lina Yang, Wei Zhou, Yongzhong Wu, Dan Tao

  • July 15, 2026

Related Content

EUS-guided transmural treatment of afferent loop syndrome: a systematic review and meta-analysis

Underutilisation of rehabilitation for children with cancer in Gaza: the experience of the non-governmental organisation Children Not Numbers

Combination therapy with anti-PD-1 antibody, radiotherapy, and tyrosine kinase inhibitor for unresectable primary ectopic hepatocellular carcinoma: a case report with genomic profiling and literature review